Acceleron Pharma Inc. XLRN
178.75 +178.75
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2020 · select a line to chart its full history
Income statement
| Fiscal year | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 | FY 2016 Dec 31, 2016 |
|---|---|---|---|---|---|
| 92.52M | 73.99M | 13.99M | 13.48M | 27.77M | |
| 92.52M | 73.99M | 13.99M | 13.48M | 27.77M | |
| -167.31M | -136.44M | -124.41M | -109.98M | -66.11M | |
| -166.03M | -124.86M | -118.87M | -108.45M | -57.01M | |
| -2.92 | -2.38 | -2.59 | -2.68 | -1.52 |
Balance sheet
| Fiscal year | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 | FY 2016 Dec 31, 2016 |
|---|---|---|---|---|---|
| 670.95M | 237.68M | 144.05M | 101.28M | 21.90M | |
| 932.34M | 504.91M | 314.82M | 389.18M | 247.65M | |
| 77.23M | 55.43M | 22.78M | 23.96M | 22.05M | |
| 24.08M | 26.38M | 0 | 0 | 0 | |
| 855.11M | 449.48M | 292.04M | 365.22M | 225.60M |
Cash flow
| Fiscal year | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 | FY 2016 Dec 31, 2016 |
|---|---|---|---|---|---|
| -130.33M | -93.80M | -94.71M | -76.54M | -44.55M | |
| 25.60M | -71.29M | 122.93M | -64.37M | -108.81M | |
| 538.01M | 258.72M | 16.15M | 220.30M | 146.67M | |
| -4.20M | -3.29M | -2.59M | -4.40M | -3.38M | |
| 433.27M | 93.63M | 44.37M | 79.39M | -6.68M |